Long-term real-world safety of ozanimod – A post-authorisation safety study (PASS) in patients diagnosed with ulcerative colitisFirst published 08/03/2024 Last updated 08/03/2024 EU PAS number: EUPAS1000000034StudyOngoing
Bordeaux PharmacoEpi, University of BordeauxFrance First published: 07/02/2023Last updated 08/02/2023 InstitutionEducational InstitutionHospital/Clinic/Other health care facilityNot-for-profitENCePP partner
The SIGMA Consortium (SIGMA)DenmarkEuropean UnionFranceGermanyItalyNetherlandsNorwaySpainSwedenUnited Kingdom First published: 10/02/2013Last updated 16/07/2024 NetworkENCePP partner